Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 28, 2007

View Archived Issues

Recent findings from antimalarial, antiviral research

Recent Novartis patents describe novel therapeutic agents for hepatitis

Recent patents describe novel therapeutic agents for infectious diseases

Eisai presents semiannual results for fiscal year ending March 31, 2008

Novel analgesic agents reported in recent patent literature

Positive clinical data for milnacipran in fibromyalgia syndrome treatment

Studies show pitrakinra improves late asthmatic response after allergen challenge

BAY-639044 evaluated in first-in-man study

Argenta and Dr. Reddy's select preclinical candidate for respiratory diseases

InterMune buys out license agreement for pirfenidone from Marnac and KDL

CytRx reports positive safety and tolerability results from clinical trial of arimoclomol

NovaBay reports positive results from phase I clinical trial of AgaNase

Antiarthritic efficacy of novel dual-variable-domain anti-IL-1alpha/IL-1beta immunoglobulins

GlaxoSmithKline obtains exclusive U.S. OTC marketing rights to Mevacor

Positive results reported in dose-escalation safety study with pramiconazole

Safety analysis completed in first patient cohort from Nventa's HspE7 trial

Sosei presents update on SD-118 neuropathic pain program

QRxPharma initiates phase III clinical trial of Q-8003-IR for acute pain

EMEA accepts for technical review MAA submission by Introgen for Advexin

FDA accepts Vanda's NDA for iloperidone for schizophrenia

Cleveland BioLabs initiates phase II trial of Curaxin for advanced renal cell carcinoma

Kinex initiates phase I clinical trial of KX2-391 for advanced solid tumors and lymphoma

E.U. approves Tasigna for Ph+ CML patients with poor response to current therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...